Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, to Present February 10th at BIO CEO & Investor Conference
Magdalena aiming to submit Investigational New Drug (IND) application in 2025 to the FDA for a next-generation psychoactive prescription drug candidate for potential mental health indications such as ...
The Scranton Times-Tribune23h
Mother’s wrongful death lawsuit claims daughter from Scranton died from kratom use
A wrongful death lawsuit claims a Scranton woman died from a product containing kratom, a botanical native to Southeast Asia.
Transcript: The Futurist: Superagency with Reid Hoffman
It's my pleasure today to be in conversation with Reid Hoffman, the co-founder of LinkedIn and the author of a new book, "Superagency: What Could Possibly Go Right With Our AI Future?" ...
FDA approves Symbravo for acute treatment of migraine in adults
The U.S. Food and Drug Administration has approved Axsome Therapeutics' Symbravo (meloxicam and rizatriptan) for the acute ...